Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03536858 · ClinicalTrials.gov registry record · NA

Social Networks and Renal Education: Promoting Transplantation

A NA study of End Stage Renal Disease and Renal Dialysis, sponsored by Temple University.

Completed
Registry status
NA
Development phase
116
Enrollment target
1
Study location

NCT03536858 is a NA study of End Stage Renal Disease and Renal Dialysis that has completed, run by Temple University. The registered enrollment target is 116 participants, below the 832-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03536858, a NA study of End Stage Renal Disease and Renal Dialysis, has completed, sponsored by Temple University.

COMPLETED
Registry status
NA
Development phase
116 participants
Enrollment target
1
Study location

Study Summary

There are significant and persistent disparities in access to kidney transplantation and as a result most patients with end stage renal disease receive hemodialysis (HD). HD is unique as it is a treatment performed in a group setting which lends itself to forming social networks. The goal of this research study is to identify and characterize the social networks of HD patients and measure the influence of HD social networks on knowledge, attitudes, and behaviors towards transplantation using repeated surveys and a network targeted educational intervention.

Interventions

  • BEHAVIORAL COACH (Communicating about Choices in Transplantation)

Study Locations (1)

Pennsylvania

  • Temple University - Philadelphia

Trial Details

FieldValue
Enrollment Target 116 participants
Start Date 2018-10-23
Est. Completion 2022-07-26
Phase NA

Sponsor

Temple University

163 total trials

What the Registry Record Tells You About NCT03536858

The ClinicalTrials.gov registry entry for NCT03536858 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 832-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (86% lower). The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with End Stage Renal Disease appearing as the primary indexed condition, and to 1 intervention - of which COACH (Communicating about Choices in Transplantation) is the first listed.

NCT03536858 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03536858 about?

NCT03536858 is a clinical study titled "Social Networks and Renal Education: Promoting Transplantation". There are significant and persistent disparities in access to kidney transplantation and as a result most patients with end stage renal disease receive hemodialysis (HD). HD is unique as it is a treatment performed in a group setting which lends itself to forming social networks. The goal of this re...

What is the current status of trial NCT03536858?

This trial is currently completed. It is a NA study. The enrollment target is 116 participants. The study started on 2018-10-23. Estimated completion is 2022-07-26.

What conditions does trial NCT03536858 study?

This clinical trial studies the following conditions: End Stage Renal Disease, Renal Dialysis, Living Donor Kidney Transplantation.

What interventions are being tested in trial NCT03536858?

The interventions under investigation include: COACH (Communicating about Choices in Transplantation) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03536858?

This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03536858 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for End Stage Renal Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.